Research on Disease Control and Mental Health Status of Adolescent Asthma Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-18
SponsorBeijing Children's Hospital

About this trial

Background: Currently in China, adolescent asthma care is characterized by both undertreatment and overtreatment. Patients in this age group may exhibit negative emotions toward disease treatment and long-term control. Insufficient disease knowledge, irregular lifestyle habits, and negative attitudes toward the disease can all reduce medication adherence, affect disease control outcomes, and thereby increase the risk of severe chronic respiratory conditions and disease burden in adulthood.

Objectives: To assess disease control status in adolescent asthma patients, evaluate the psychological well-being of patients and their family members, and understand patients' self-management skills and readiness for transition to adulthood.

Procedures: Eligible participants will complete a series of assessment questionnaires through the Youran Huxi mobile application, including questionnaires on asthma control, physical activity, psychological health, self-management behaviors, and transition readiness. The study period is 12 months; the baseline assessment involves one-time completion of written questionnaires with no interim follow-up visits. The study does not intervene in clinical diagnosis or treatment decisions.

Eligibility criteria

Qualifiers

Meet the asthma diagnostic criteria of GINA 2025

Age 12 to 18 years old

The parents and the child patient agreed and filled out the questionnaire completely.

Disqualifiers

Children with other respiratory diseases such as bronchiectasis, bronchiolitis, cystic fibrosis and pneumonia

Combined with chronic diseases of other systems

Trial design

Treatments tested in this trial

  • Eligible participants will complete a battery of assessment questionnaires

Treatment groups

460 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators